# Oxytocin in Spectrum Autism Disorders

> **NCT03183674** · PHASE1 · COMPLETED · sponsor: **University of Sao Paulo General Hospital** · enrollment: 80 (actual)

## Conditions studied

- Autistic Disorder

## Interventions

- **DRUG:** Oxytocin
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT03183674
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-15
- **Primary completion:** 2017-07-20
- **Final completion:** 2018-05-15
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03183674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03183674, "Oxytocin in Spectrum Autism Disorders". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03183674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*